Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wismann Holding ApS is a Danish investment and holding company founded and led by Lars Wismann. The firm is primarily active in the life sciences sector as a significant and vocal shareholder of Bavarian Nordic A/S, a global biotechnology company specializing in innovative vaccines. Wismann Holding is known for its shareholder activism, frequently engaging with corporate boards to advocate for strategic changes aimed at maximizing shareholder value and stock performance. Beyond its focus on biotechnology, the group manages a diverse portfolio that includes real estate interests through its affiliate, Wismann Property Consult. The company remains a private entity based in Denmark, representing the investment interests of the Wismann family. It is frequently cited in financial media for its persistent efforts to influence the governance of major Danish healthcare and financial institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wismann Holding.